Late toxicity after short course preoperative radiotherapy and total mesorectal excision for resectable rectal cancer

被引:13
|
作者
King, M
Tolan, S
Giridharan, S
McConkey, C
Hartley, A [1 ]
Geh, JI
机构
[1] Queen Elizabeth Hosp, Ctr Canc, Birmingham B15 2TH, W Midlands, England
[2] Univ Birmingham, Canc Res UK Clin Trials Unit, Birmingham, W Midlands, England
关键词
late toxicity; radiotherapy; rectal cancer;
D O I
10.1016/S0936-6555(03)00118-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: The late toxicity of short-course preoperative radiotherapy (SCPRT) after total mesorectal excision (TME) in resectable rectal cancer has not been adequately documented. The acute toxicity in a series of 176 consecutive patients has been previously reported. In this study, the late toxicity in the same cohort is presented. Materials and Methods: Side-effects occurring more than 3 months after the start of SCPRT were graded using the EORTC/RTOG late radiation toxicity system. We performed multivariate analysis to identify associated factors. Results: Of 176 patients, 15 died within 3 months of SCPRT and five patients were lost to follow-up. One hundred and fifty-six patients were assessable at a median follow-up interval of 41 months: severe (grade 3-4) toxicity was seen in 20 patients (13%), of which 13 were gastrointestinal (8%); three urological (2%); three thromboembolic (2%), and one musculoskeletal (1%). On multivariate analysis, abdomino-perineal (AP) resection (P<0.02) was associated with a lower risk of grade 3-4 toxicity. Conclusions: In this retrospective study, the rate of late grade 3-4 toxicity after SCPRT and TME was 13%. Although AP resection seems to be associated with a lower incidence of late toxicity, this could be counterbalanced by the impact of a stoma on quality of life. These factors should be considered when determining the optimal management of resectable rectal cancers. (C) 2003 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:233 / 236
页数:4
相关论文
共 50 条
  • [1] Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer
    Kapiteijn, E
    Marijnen, CAM
    Nagtegaal, ID
    Putter, H
    Steup, WH
    Wiggers, T
    Rutten, HJT
    Pahlman, L
    Glimelius, B
    van Krieken, JHJM
    Leer, JWH
    van de Velde, CJH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (09): : 638 - 646
  • [2] Clinical results and toxicity for short-course preoperative radiotherapy and total mesorectal excision in rectal cancer patients
    Sterzing, Florian
    Hoehle, Frieder
    Ulrich, Alexis
    Jensen, Alexandra
    Debus, Juergen
    Muenter, Marc
    [J]. JOURNAL OF RADIATION RESEARCH, 2015, 56 (01) : 169 - 176
  • [3] Late effects following total mesorectal excision and short course preoperative radiotherapy
    King, M
    Tolan, S
    Giridharan, S
    McConkey, C
    Hartley, A
    Geh, I
    [J]. BRITISH JOURNAL OF CANCER, 2003, 88 : S20 - S20
  • [4] Local recurrence of rectal cancer after total mesorectal excision without preoperative radiotherapy
    Christiaan P. van Lingen
    Clark J. Zeebregts
    Jos J. G. M. Gerritsen
    H. Jan Mulder
    Walter J. B. Mastboom
    Joost M. Klaase
    [J]. International Journal of Gastrointestinal Cancer, 2003, 34 (2-3): : 129 - 134
  • [5] Late toxicity following short course preoperative radiotherapy for operable rectal cancer
    King, M
    Tolan, S
    Giridharan, S
    McConkey, C
    Hartley, A
    Geh, JI
    [J]. GUT, 2003, 52 : A90 - A90
  • [6] Rectal cancer: additional benefit of a preoperative radiotherapy combined with total mesorectal excision
    Roseau, E
    [J]. PRESSE MEDICALE, 2002, 31 (16): : 725 - 726
  • [7] Bowel Function 14 Years After Preoperative Short-Course Radiotherapy and Total Mesorectal Excision for Rectal Cancer: Report of a Multicenter Randomized Trial
    Chen, Tina Yen-Ting
    Wiltink, Lisette M.
    Nout, Remi A.
    Kranenbarg, Elma Meershoek-Klein
    Laurberg, Soren
    Marijnen, Corrie A. M.
    van de Velde, Cornelis J. H.
    [J]. CLINICAL COLORECTAL CANCER, 2015, 14 (02) : 106 - 114
  • [8] Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer
    Kapiteijn, E
    van Krieken, JHJM
    Hermans, J
    Leer, JWH
    van de Velde, CJH
    [J]. EUROPEAN JOURNAL OF CANCER, 1998, 34 : S13 - S13
  • [9] Clinical nature and prognosis of locally recurrent rectal cancer after total mesorectal excision with or without preoperative radiotherapy
    van den Brink, M
    Stiggelbout, AM
    van den Hout, WB
    Kievit, J
    Kranenbarg, EK
    Marijnen, CAM
    Nagtegaal, ID
    Rutten, HJT
    Wiggers, T
    van de Velde, CJH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (19) : 3958 - 3964
  • [10] SURGICAL MORBIDITY AND LONG-TERM ONCOLOGICAL OUTCOMES AFTER SHORT COURSE RADIOTHERAPY AND TOTAL MESORECTAL EXCISION FOR RECTAL CANCER.
    Lieske, B.
    Robertson, R.
    Barnes, R.
    Gildersleve, J.
    Conaghan, P.
    Farouk, R.
    [J]. DISEASES OF THE COLON & RECTUM, 2010, 53 (04) : 643 - 643